Detection and resection of carcinoma in situ of the bladder: Implications for clinical trial design

•carcinoma in situ (CIS) is under-detected by routine endoscopic evaluation of the bladder.•CIS may be surgically eradicated in a proportion of patients.•Single arm trials may over-estimate complete response rate since some responses are likely achieved by complete resection of CIS and others are li...

Ausführliche Beschreibung